Insulet (PODD) Q2 Revenue Beats

Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.50), which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $291.45 million.

GUIDANCE:

For the year ending December 31, 2022, the Company is raising its revenue growth guidance range to 14% to 17% (previously 12% to 16%). Revenue growth ranges by product line are:

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Reiterates Buy Rating on Linde (LIN) as Challenges in Helium Are 'Being Managed'
• Dell’s earning report was bullish for Intel CPU demand, analyst says